Roger Kamm,
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering,
Massachusetts Institute of Technology (MIT)
Kamm is currently the Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at MIT, where he has served on the faculty since 1978. Kamm has long been instrumental in developing research activities at the interface of biology and mechanics, formerly in cell and molecular mechanics, and now in engineered living systems. Current interests are in developing models of healthy and diseased organ function using microfluidic technologies, with a focus on vascularization, metastatic cancer and neurological disease. Kamm has fostered biomechanics as Chair of the US National Committee on Biomechanics (2006-2009) and of the World Council on Biomechanics (2006-2010). For 10 years, he was Director of the NSF Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems. He is the 2010 recipient of the ASME Lissner Medal and the 2015 recipient of the Huiskes Medal, both for lifetime achievements, and was the inaugural recipient of the ASME Nerem Medal for mentoring and education. He was elected to the National Academy of Medicine in 2010 and Engineering in 2022. Kamm is co-founder of AIM Biotech, a manufacturer of microfluidic systems for 3D culture.
Models of Neurological Disease
Monday, 14 October 2019 at 11:00
Add to Calendar ▼2019-10-14 11:00:002019-10-14 12:00:00Europe/LondonModels of Neurological Disease3D-Printing in the Life Sciences in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com
Many of the most debilitating and life-threatening diseases are
associated with the central nervous system. Some, such as
neurodegenerative diseases, predominately afflict our aging population.
Yet others such as brain cancers and ALS are prevalent among young and
old alike. In this presentation, models will be presented that attempt
to recapitulate certain aspects of the brain and these diseases, both to
probe the disease process, and as a platform to screen for new
therapeutics. Three examples will be presented. First, a model for the
healthy blood-brain barrier and neurovascular unit have been developed
in order to capture the essential aspects associated with these
diseases. Second, the blood-brain barrier model is used to study
metastasis of cancers to the brain, as well as primary glioblastoma. In
the third part of the talk, a model for the healthy and diseased
neuromuscular junction will be presented as a step toward developing
therapeutic strategies for treating ALS.
Add to Calendar ▼2019-10-14 00:00:002019-10-15 00:00:00Europe/London3D-Printing in the Life Sciences3D-Printing in the Life Sciences in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com